FDA has stated it is making ‘substantial progress’ with CBD, and a new enforcement guidance could be very significant for the industry, said NPA’s Dr Daniel Fabricant, but he said the Agency needs to ‘get in the game’ for NDIs.
Danish biotech company Biosyntia are to collaborate with French biotech start-up Lantana in a pact that looks to offer natural isoflavonoids at a higher purity and produced in a more cost-effective way.
Daily supplementation with a standardized ashwagandha extract (Shoden) may reduce the amount of nonrestorative sleep experienced by healthy adults, says data from a gold-standard randomized, double blind, placebo-controlled trial.
Preliminary data suggests a probiotic formulation could act as a complementary remedy to slow down the progression of COVID-19 as researchers stress the gut-lung axis’ importance in controlling the disease.
A pilot study from Japan found that astaxanthin supplementation for three months can suppress oxidative stress and improve cardiac function and exercise tolerance in patients suffering from heart failure.
The US Food and Drug Administration will not object to the use of certain qualified health claims regarding consuming certain cranberry juice and supplements and a reduced risk of recurrent urinary tract infection (UTI) in healthy women.
Japanese dairy product company Morinaga Milk Industry has revealed plans to expand its yoghurt range by introducing more products with functional benefits, accelerate its lactoferrin research and e-commerce business as part of its key initiatives for...
UK watchdogs are reminding firms that stating or implying substances in food supplements can prevent, treat or cure disease is prohibited as authorities look to clamp down on recent coronavirus-related claims.